Trial Profile
Efficacy of Rilpivirine-based Regimens as Switch Therapy From Nevirapine-based Regimens in HIV-infected Patients With Complete Virological Suppression: A Randomized Controlled Trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Rilpivirine (Primary) ; Emtricitabine; Lamivudine; Nevirapine; Tenofovir disoproxil fumarate
- Indications HIV-1 infections
- Focus Therapeutic Use
- 18 Sep 2018 New trial record